<?xml version="1.0" encoding="UTF-8"?>
<p>The BSR suggests that patients at this chronic stage should be tested for chikungunya IgG serology and should also have specific tests for differential diagnoses with other rheumatological diseases, including rheumatoid factor, citrullinated anti-peptide antibody, and in suspected cases of spondyloarthritis should be serchead the human leucocyte antigen B27. </p>
